<DOC>
	<DOCNO>NCT02408120</DOCNO>
	<brief_summary>The purpose study test whether use extra dos aspart insulin correct blood sugar meals improves care patient type 2 diabetes hospital already receive standard care treatment glargine aspart insulin injection control blood sugar level . Studies do past indicate blood sugar level control standard treatment insulin patient need small extra dose insulin bedtime . The investigator want test benefit give patient extra dos insulin day correct high blood sugar .</brief_summary>
	<brief_title>Benefits Insulin Supplementation Correction Hyperglycemia Patients With Type 2 Diabetes</brief_title>
	<detailed_description>The management patient Type 2 diabetes involve treatment two different type insulin injection control blood sugar level . The dos two type insulin , glargine insulin aspart insulin adjust daily hospital stay base blood sugar level . Many time , addition glargine aspart insulin meal , additional small dos aspart insulin give correct high blood sugar level . It determine use extra dos aspart insulin correct blood sugar meals improves care patient . Studies do past indicate blood sugar level well control standard treatment two insulin patient need small extra dose insulin bedtime . This study test insulin supplementation improve glycemic control prevent hypoglycemia insulin treat patient type 2 diabetes mellitus .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Hyperglycemia</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>1 . Subjects admit hospital acute chronic medical illness elective emergency surgical illness trauma 2 . Known history Type 2 diabetes mellitus &gt; 3 month 3 . Treated either diet alone , combination oral antidiabetic agent , noninsulin injectables insulin therapy 4 . Blood glucose level &gt; 140 mg &lt; 400 mg/dL without laboratory evidence diabetic ketoacidosis 1 . Hyperglycemia without history diabetes 2 . Subjects acute critical illness admit ICU expect require ICU admission 3 . Subjects receive continuous insulin infusion 4 . Clinically relevant hepatic disease 5 . Corticosteroid therapy 6 . Serum creatinine â‰¥ 3.5 mg/dL and/or glomerular filtration rate ( GFR ) &lt; 30 7 . Subjects unable sign consent 8 . Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Hyperglycemia</keyword>
	<keyword>Hypoglycemia</keyword>
</DOC>